相关实验视频

Updated: Jun 11, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

药物耐药性人类的威胁不断升级:当前见解和未来方向

Thierry Simonart¹, Xuân-Lan Lam Hoai²

¹Department of Dermatology, Delta Hospital, CHIREC, Université Libre de Bruxelles, 1160 Bruxelles, Belgium.

Journal of clinical medicine

|September 28, 2024

概括

耐药,特别是耐的菌株,是一个越来越令人担忧的问题. 新的管理策略和替代治疗方法对于应对这种不断升级的公共卫生威胁至关重要.

科学领域:

皮肤病学皮肤病学
寄生虫学的寄生虫学
公共卫生公共卫生

背景情况:

是一种常见的皮肤感染,具有显著的全球健康影响.
的抗药性增加给治疗和控制带来了挑战.
甲状腺的甲基氨酸耐药性是一个记录和日益增长的问题.

研究的目的:

审查当前关于耐药的文献.
识别耐药性机制并评估治疗疗效.
突出需要更新管理策略的需要.

主要方法:

在PubMed,Cochrane图书馆和科学网上进行了全面的文献搜索.
包括2000年至2024年8月发表的研究.
专注于耐药和治疗进展.

主要成果:

在人类中证实了显著的氨酸耐药性,与VGSCs突变和GST活动有关.
耐药性较少明显,具有有限的临床证据.
实验室和事证据表明潜在的耐药性,但广泛的耐药性尚未得到证实.

结论:

耐氨酸是一种日益增长的威胁,需要采取新的控制措施.
替代治疗方法和更新的指导方针对于有效的病管理至关重要.
对新型治疗药物的持续研究对于解决耐药性至关重要.

关键词:

基酸是什么基酸是什么基酸是什么我从来没有使用过mectin.甲氨酸是什么甲氨酸电阻的阻力可以病病病是一种疾病.

更多相关视频

A High-throughput, High-content, Liquid-based C. elegans Pathosystem

A High-throughput, High-content, Liquid-based C. elegans Pathosystem

Published on: July 1, 2018

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...